annual EBITDA:
$9.11B-$2.19B(-19.36%)Summary
- As of today (May 20, 2025), GSK annual EBITDA is $9.11 billion, with the most recent change of -$2.19 billion (-19.36%) on December 31, 2024.
- During the last 3 years, GSK annual EBITDA has risen by +$192.00 million (+2.15%).
- GSK annual EBITDA is now -53.74% below its all-time high of $19.70 billion, reached on December 31, 2015.
Performance
GSK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$3.89B+$2.46B(+171.84%)Summary
- As of today (May 20, 2025), GSK quarterly EBITDA is $3.89 billion, with the most recent change of +$2.46 billion (+171.84%) on March 31, 2025.
- Over the past year, GSK quarterly EBITDA has increased by +$1.27 billion (+48.33%).
- GSK quarterly EBITDA is now -75.53% below its all-time high of $15.92 billion, reached on March 31, 2015.
Performance
GSK quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$9.76B+$1.27B(+14.94%)Summary
- As of today (May 20, 2025), GSK TTM EBITDA is $9.76 billion, with the most recent change of +$1.27 billion (+14.94%) on March 31, 2025.
- Over the past year, GSK TTM EBITDA has dropped by -$815.49 million (-7.71%).
- GSK TTM EBITDA is now -55.01% below its all-time high of $21.70 billion, reached on March 31, 2015.
Performance
GSK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GSK EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.4% | +48.3% | -7.7% |
| 3 y3 years | +2.1% | +6.8% | -6.1% |
| 5 y5 years | -24.3% | +34.6% | -15.7% |
GSK EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.4% | +2.1% | at high | +171.8% | -18.8% | +14.9% |
| 5 y | 5-year | -24.3% | +2.1% | at high | +264.8% | -20.1% | +14.9% |
| alltime | all time | -53.7% | >+9999.0% | -75.5% | +145.9% | -55.0% | +3930.3% |
GSK EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $3.89B(+171.8%) | $9.76B(+14.9%) |
| Dec 2024 | $9.11B(-19.4%) | $1.43B(-6.0%) | $8.49B(-0.1%) |
| Sep 2024 | - | $1.52B(-47.7%) | $8.50B(-16.7%) |
| Jun 2024 | - | $2.91B(+10.9%) | $10.21B(-3.5%) |
| Mar 2024 | - | $2.63B(+82.7%) | $10.58B(-6.3%) |
| Dec 2023 | $11.30B(+6.1%) | $1.44B(-55.5%) | $11.30B(-6.1%) |
| Sep 2023 | - | $3.23B(-1.6%) | $12.03B(+6.0%) |
| Jun 2023 | - | $3.28B(-1.7%) | $11.35B(+7.1%) |
| Mar 2023 | - | $3.34B(+54.2%) | $10.60B(-2.8%) |
| Dec 2022 | $10.65B(+19.4%) | $2.17B(-15.1%) | $10.90B(+11.2%) |
| Sep 2022 | - | $2.55B(+0.6%) | $9.80B(-5.9%) |
| Jun 2022 | - | $2.54B(-30.4%) | $10.41B(+0.1%) |
| Mar 2022 | - | $3.65B(+241.4%) | $10.40B(+8.1%) |
| Dec 2021 | $8.92B(-13.8%) | $1.07B(-66.3%) | $9.62B(-9.7%) |
| Sep 2021 | - | $3.17B(+25.5%) | $10.66B(-0.7%) |
| Jun 2021 | - | $2.52B(-12.1%) | $10.74B(-8.8%) |
| Mar 2021 | - | $2.87B(+36.1%) | $11.78B(-0.2%) |
| Dec 2020 | $10.35B(-14.0%) | $2.11B(-35.0%) | $11.80B(-2.6%) |
| Sep 2020 | - | $3.24B(-8.9%) | $12.12B(-0.8%) |
| Jun 2020 | - | $3.56B(+23.0%) | $12.22B(+5.5%) |
| Mar 2020 | - | $2.89B(+19.2%) | $11.59B(-5.1%) |
| Dec 2019 | $12.05B(+22.8%) | $2.43B(-27.3%) | $12.21B(-2.9%) |
| Sep 2019 | - | $3.34B(+14.1%) | $12.57B(+1.3%) |
| Jun 2019 | - | $2.93B(-16.9%) | $12.40B(+14.4%) |
| Mar 2019 | - | $3.52B(+26.3%) | $10.84B(+11.2%) |
| Dec 2018 | $9.81B(+22.8%) | $2.79B(-12.1%) | $9.75B(+25.7%) |
| Sep 2018 | - | $3.17B(+132.0%) | $7.76B(-2.7%) |
| Jun 2018 | - | $1.37B(-43.7%) | $7.98B(-0.5%) |
| Mar 2018 | - | $2.43B(+205.4%) | $8.02B(-1.7%) |
| Dec 2017 | $7.98B(+33.0%) | $795.42M(-76.5%) | $8.16B(-8.1%) |
| Sep 2017 | - | $3.39B(+140.8%) | $8.88B(+16.1%) |
| Jun 2017 | - | $1.41B(-45.1%) | $7.65B(+15.5%) |
| Mar 2017 | - | $2.56B(+69.0%) | $6.62B(+11.9%) |
| Dec 2016 | $6.00B(-69.5%) | $1.52B(-29.8%) | $5.92B(+32.4%) |
| Sep 2016 | - | $2.16B(+465.2%) | $4.47B(+4.3%) |
| Jun 2016 | - | $382.09M(-79.5%) | $4.28B(-22.7%) |
| Mar 2016 | - | $1.86B(+2624.3%) | $5.54B(-71.7%) |
| Dec 2015 | $19.70B(+131.8%) | $68.26M(-96.5%) | $19.60B(-6.1%) |
| Sep 2015 | - | $1.97B(+20.3%) | $20.88B(+0.6%) |
| Jun 2015 | - | $1.64B(-89.7%) | $20.75B(-4.4%) |
| Mar 2015 | - | $15.92B(+1082.3%) | $21.70B(+154.5%) |
| Dec 2014 | $8.50B(-38.3%) | $1.35B(-27.2%) | $8.53B(-26.1%) |
| Sep 2014 | - | $1.85B(-28.5%) | $11.54B(-13.2%) |
| Jun 2014 | - | $2.59B(-5.7%) | $13.30B(-3.8%) |
| Mar 2014 | - | $2.74B(-37.1%) | $13.83B(-4.4%) |
| Dec 2013 | $13.77B(-1.3%) | $4.36B(+21.1%) | $14.46B(+1.4%) |
| Sep 2013 | - | $3.60B(+15.5%) | $14.26B(+3.8%) |
| Jun 2013 | - | $3.12B(-7.6%) | $13.74B(+0.0%) |
| Mar 2013 | - | $3.38B(-18.9%) | $13.74B(-1.6%) |
| Dec 2012 | $13.95B(-11.9%) | $4.16B(+35.1%) | $13.96B(+6.4%) |
| Sep 2012 | - | $3.08B(-1.0%) | $13.12B(-8.9%) |
| Jun 2012 | - | $3.11B(-13.5%) | $14.40B(-3.9%) |
| Mar 2012 | - | $3.60B(+8.4%) | $14.98B(-5.5%) |
| Dec 2011 | $15.84B(+82.8%) | $3.32B(-23.9%) | $15.85B(+28.1%) |
| Sep 2011 | - | $4.36B(+17.9%) | $12.37B(+3.3%) |
| Jun 2011 | - | $3.70B(-17.1%) | $11.98B(+31.6%) |
| Mar 2011 | - | $4.46B(-3013.7%) | $9.11B(+4.7%) |
| Dec 2010 | $8.67B(-46.0%) | -$153.23M(-103.9%) | $8.70B(-35.0%) |
| Sep 2010 | - | $3.97B(+380.6%) | $13.39B(-2.1%) |
| Jun 2010 | - | $825.83M(-79.6%) | $13.67B(-17.5%) |
| Mar 2010 | - | $4.06B(-10.6%) | $16.57B(+3.1%) |
| Dec 2009 | $16.03B(-0.7%) | $4.54B(+6.7%) | $16.06B(+11.1%) |
| Sep 2009 | - | $4.25B(+14.4%) | $14.46B(+1.1%) |
| Jun 2009 | - | $3.72B(+4.7%) | $14.30B(-5.9%) |
| Mar 2009 | - | $3.55B(+21.1%) | $15.19B(-6.8%) |
| Dec 2008 | $16.15B(-12.5%) | $2.93B(-28.3%) | $16.29B(-9.8%) |
| Sep 2008 | - | $4.09B(-11.2%) | $18.06B(+21.5%) |
| Jun 2008 | - | $4.61B(-1.0%) | $14.87B(+0.7%) |
| Mar 2008 | - | $4.66B(-0.9%) | $14.76B(-1.7%) |
| Dec 2007 | $18.46B(+14.3%) | $4.70B(+419.2%) | $15.02B(+13.5%) |
| Sep 2007 | - | $905.16M(-79.9%) | $13.24B(-22.8%) |
| Jun 2007 | - | $4.50B(-8.4%) | $17.15B(+2.2%) |
| Mar 2007 | - | $4.91B(+68.4%) | $16.79B(+4.3%) |
| Dec 2006 | $16.16B(+600.6%) | $2.92B(-39.5%) | $16.09B(+242.9%) |
| Sep 2006 | - | $4.82B(+16.4%) | $4.69B(+20.5%) |
| Jun 2006 | - | $4.14B(-1.7%) | $3.89B(+13.8%) |
| Mar 2006 | - | $4.21B(-149.7%) | $3.42B(+21.6%) |
| Dec 2005 | $2.31B(-81.0%) | -$8.48B(-310.9%) | $2.81B(-79.3%) |
| Sep 2005 | - | $4.02B(+9.7%) | $13.61B(+5.6%) |
| Jun 2005 | - | $3.67B(+1.7%) | $12.89B(+0.6%) |
| Mar 2005 | - | $3.61B(+56.0%) | $12.82B(+2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2004 | $12.12B(+2.3%) | $2.31B(-30.1%) | $12.55B(+2.1%) |
| Sep 2004 | - | $3.31B(-8.0%) | $12.29B(-0.3%) |
| Jun 2004 | - | $3.59B(+7.5%) | $12.33B(+1.5%) |
| Mar 2004 | - | $3.34B(+63.3%) | $12.14B(+3.0%) |
| Dec 2003 | $11.84B(+20.6%) | $2.05B(-38.8%) | $11.79B(-4.1%) |
| Sep 2003 | - | $3.34B(-1.9%) | $12.29B(+10.9%) |
| Jun 2003 | - | $3.41B(+14.2%) | $11.08B(+7.2%) |
| Mar 2003 | - | $2.99B(+17.2%) | $10.34B(+5.5%) |
| Dec 2002 | $9.82B(-1.4%) | $2.55B(+18.9%) | $9.79B(-16.6%) |
| Sep 2002 | - | $2.14B(-19.6%) | $11.75B(+7.2%) |
| Jun 2002 | - | $2.66B(+9.0%) | $10.96B(+3.0%) |
| Mar 2002 | - | $2.44B(-45.7%) | $10.64B(+6.8%) |
| Dec 2001 | $9.96B(-7.5%) | $4.50B(+233.0%) | $9.96B(+5.7%) |
| Sep 2001 | - | $1.35B(-42.2%) | $9.42B(-3.2%) |
| Jun 2001 | - | $2.34B(+32.5%) | $9.73B(+3.6%) |
| Mar 2001 | - | $1.77B(-55.5%) | $9.40B(-4.1%) |
| Dec 2000 | $10.77B(+107.5%) | $3.97B(+138.9%) | $9.80B(+3945.8%) |
| Sep 2000 | - | $1.66B(-17.2%) | $242.24M(-89.1%) |
| Jun 2000 | - | $2.00B(-7.6%) | $2.23B(+53.9%) |
| Mar 2000 | - | $2.17B(-138.8%) | $1.45B(-43.6%) |
| Dec 1999 | $5.19B(-3.0%) | -$5.59B(-253.4%) | $2.57B(-16.0%) |
| Sep 1999 | - | $3.65B(+197.7%) | $3.05B(+8.8%) |
| Jun 1999 | - | $1.22B(-62.7%) | $2.81B(+2.5%) |
| Mar 1999 | - | $3.29B(-164.4%) | $2.74B(+4.1%) |
| Dec 1998 | $5.36B(-0.5%) | -$5.11B(-250.1%) | $2.63B(+10.6%) |
| Sep 1998 | - | $3.40B(+194.3%) | $2.38B(+6.6%) |
| Jun 1998 | - | $1.16B(-63.7%) | $2.23B(-48.9%) |
| Mar 1998 | - | $3.18B(-159.3%) | $4.37B(-3.5%) |
| Dec 1997 | $5.38B(-5.6%) | -$5.36B(-264.7%) | $4.53B(-35.7%) |
| Sep 1997 | - | $3.25B(-1.1%) | $7.04B(-8.0%) |
| Jun 1997 | - | $3.29B(-1.4%) | $7.65B(+1.4%) |
| Mar 1997 | - | $3.34B(-217.3%) | $7.55B(+1.1%) |
| Dec 1996 | $5.70B(+10.9%) | -$2.85B(-173.6%) | $7.47B(-27.6%) |
| Sep 1996 | - | $3.87B(+21.3%) | $10.31B(+14.5%) |
| Jun 1996 | - | $3.19B(-2.1%) | $9.01B(+1745.6%) |
| Mar 1996 | - | $3.26B(+27.0%) | $488.17M(-79.4%) |
| Dec 1995 | $5.14B(+82.6%) | - | - |
| Sep 1995 | - | $2.56B(-148.1%) | $2.37B(+1.4%) |
| Jun 1995 | - | -$5.33B(-310.9%) | $2.34B(-41.0%) |
| Jun 1995 | $2.82B(-12.9%) | - | - |
| Mar 1995 | - | $2.53B(-3.3%) | $3.97B(+7.2%) |
| Dec 1994 | - | $2.61B(+3.3%) | $3.70B(+15.4%) |
| Sep 1994 | - | $2.53B(-168.3%) | $3.21B(+15.8%) |
| Jun 1994 | $3.23B(+1.7%) | -$3.71B(-263.9%) | $2.77B(-14.6%) |
| Mar 1994 | - | $2.26B(+6.6%) | $3.24B(+1.0%) |
| Dec 1993 | - | $2.12B(+1.3%) | $3.21B(+10.8%) |
| Sep 1993 | - | $2.09B(-164.8%) | $2.90B(+8.7%) |
| Jun 1993 | $3.18B(+7.5%) | -$3.23B(-245.0%) | $2.66B(+5.8%) |
| Mar 1993 | - | $2.23B(+23.3%) | $2.52B(+10.9%) |
| Dec 1992 | - | $1.81B(-2.9%) | $2.27B(-1.8%) |
| Sep 1992 | - | $1.86B(-155.1%) | $2.31B(-0.5%) |
| Jun 1992 | $2.96B(+5.6%) | -$3.38B(-270.5%) | $2.33B(-41.3%) |
| Mar 1992 | - | $1.98B(+7.2%) | $3.96B(+13.4%) |
| Dec 1991 | - | $1.85B(-1.3%) | $3.49B(+15.1%) |
| Sep 1991 | - | $1.87B(-207.3%) | $3.03B(+19.9%) |
| Jun 1991 | $2.80B(+27.6%) | -$1.75B(-215.4%) | $2.53B(-0.9%) |
| Mar 1991 | - | $1.51B(+8.7%) | $2.55B(+9.2%) |
| Dec 1990 | - | $1.39B(+1.5%) | $2.34B(+9.3%) |
| Sep 1990 | - | $1.37B(-179.5%) | $2.14B(+9.4%) |
| Jun 1990 | $2.19B(+13.6%) | -$1.72B(-232.7%) | $1.96B(-20.5%) |
| Mar 1990 | - | $1.30B(+8.8%) | $2.46B(+12.8%) |
| Dec 1989 | - | $1.19B(+0.5%) | $2.18B(+9.3%) |
| Sep 1989 | - | $1.19B(-197.3%) | $1.99B(+9.3%) |
| Jun 1989 | $1.93B(+18.9%) | -$1.22B(-219.8%) | $1.82B(-9.2%) |
| Mar 1989 | - | $1.02B(+1.1%) | $2.01B(+8.3%) |
| Dec 1988 | - | $1.01B(-1.1%) | $1.85B(+11.6%) |
| Sep 1988 | - | $1.02B(-198.4%) | $1.66B(+10.4%) |
| Jun 1988 | $1.62B(+31.1%) | -$1.03B(-219.8%) | $1.51B(-10.5%) |
| Mar 1988 | - | $863.72M(+6.1%) | $1.68B(+9.7%) |
| Dec 1987 | - | $814.42M(-5.5%) | $1.53B(+13.5%) |
| Sep 1987 | - | $862.23M(-200.4%) | $1.35B(+16.3%) |
| Jun 1987 | $1.24B(+30.1%) | -$858.44M(-220.2%) | $1.16B(-7.3%) |
| Mar 1987 | - | $714.30M(+12.9%) | $1.25B(+15.9%) |
| Dec 1986 | - | $632.59M(-6.0%) | $1.08B(+8.4%) |
| Sep 1986 | - | $672.76M(-187.7%) | $995.94M(+15.3%) |
| Jun 1986 | $951.97M(>+9900.0%) | -$767.31M(-241.6%) | $863.62M(-47.0%) |
| Mar 1986 | - | $542.04M(-1.2%) | $1.63B(+49.8%) |
| Dec 1985 | - | $548.45M(+1.5%) | $1.09B(+101.5%) |
| Sep 1985 | - | $540.44M | $540.44M |
| Jun 1985 | $0.00(0.0%) | - | - |
| Jun 1984 | $0.00 | - | - |
FAQ
- What is GSK annual EBITDA?
- What is the all time high annual EBITDA for GSK?
- What is GSK annual EBITDA year-on-year change?
- What is GSK quarterly EBITDA?
- What is the all time high quarterly EBITDA for GSK?
- What is GSK quarterly EBITDA year-on-year change?
- What is GSK TTM EBITDA?
- What is the all time high TTM EBITDA for GSK?
- What is GSK TTM EBITDA year-on-year change?
What is GSK annual EBITDA?
The current annual EBITDA of GSK is $9.11B
What is the all time high annual EBITDA for GSK?
GSK all-time high annual EBITDA is $19.70B
What is GSK annual EBITDA year-on-year change?
Over the past year, GSK annual EBITDA has changed by -$2.19B (-19.36%)
What is GSK quarterly EBITDA?
The current quarterly EBITDA of GSK is $3.89B
What is the all time high quarterly EBITDA for GSK?
GSK all-time high quarterly EBITDA is $15.92B
What is GSK quarterly EBITDA year-on-year change?
Over the past year, GSK quarterly EBITDA has changed by +$1.27B (+48.33%)
What is GSK TTM EBITDA?
The current TTM EBITDA of GSK is $9.76B
What is the all time high TTM EBITDA for GSK?
GSK all-time high TTM EBITDA is $21.70B
What is GSK TTM EBITDA year-on-year change?
Over the past year, GSK TTM EBITDA has changed by -$815.49M (-7.71%)